IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIAGIOLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.838
AS - Asia 1.986
EU - Europa 1.697
SA - Sud America 300
AF - Africa 36
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.864
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.753
SG - Singapore 892
IT - Italia 526
CN - Cina 367
IE - Irlanda 354
HK - Hong Kong 295
BR - Brasile 245
RU - Federazione Russa 216
VN - Vietnam 198
DE - Germania 126
FI - Finlandia 77
GB - Regno Unito 71
KR - Corea 70
SE - Svezia 54
CA - Canada 49
FR - Francia 44
PL - Polonia 43
UA - Ucraina 39
AT - Austria 36
IN - India 27
MX - Messico 25
AR - Argentina 23
JP - Giappone 23
NL - Olanda 23
ZA - Sudafrica 22
BE - Belgio 19
TR - Turchia 19
ES - Italia 16
CH - Svizzera 14
BD - Bangladesh 13
EC - Ecuador 13
IQ - Iraq 13
ID - Indonesia 11
SA - Arabia Saudita 8
UZ - Uzbekistan 7
LB - Libano 6
LT - Lituania 6
PK - Pakistan 6
VE - Venezuela 6
TW - Taiwan 5
CI - Costa d'Avorio 4
CO - Colombia 4
CZ - Repubblica Ceca 4
GR - Grecia 4
IL - Israele 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
IR - Iran 3
KW - Kuwait 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EU - Europa 2
GP - Guadalupe 2
HU - Ungheria 2
JO - Giordania 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CV - Capo Verde 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ME - Montenegro 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
Totale 6.864
Salva come PNG Salva come JPEG
Città #
Singapore 633
Chandler 501
Dublin 349
Hong Kong 294
Perugia 235
Ashburn 218
San Mateo 196
Santa Clara 121
Boardman 113
Dong Ket 96
Moscow 87
Ann Arbor 85
Beijing 81
Medford 76
Princeton 75
Los Angeles 68
Seoul 68
Altamura 63
Munich 59
Lawrence 52
Wilmington 51
New York 48
Dearborn 41
Warsaw 40
Andover 37
Ho Chi Minh City 35
São Paulo 30
Brooklyn 28
Turku 27
Dallas 26
Hanoi 26
Piscataway 25
Houston 23
Redmond 23
Tokyo 22
Vienna 19
Brussels 18
Chicago 18
Helsinki 18
Redwood City 18
Johannesburg 17
Montreal 17
Hefei 16
Norwalk 16
Saint Petersburg 16
Denver 15
Stockholm 15
Bologna 14
Poplar 13
Atlanta 12
Chennai 12
Florence 12
London 12
Nuremberg 12
Orem 12
Rome 11
Shanghai 11
Toronto 11
Mexico City 10
San Francisco 10
Ankara 9
Columbus 9
Seattle 9
Vicenza 9
Amsterdam 8
Den Haag 8
Lappeenranta 8
Naples 8
Cambridge 7
Frankfurt am Main 7
Phoenix 7
Querétaro 7
Des Moines 6
Izmir 6
Jacksonville 6
Quito 6
San Diego 6
San Paolo di Civitate 6
The Dalles 6
Woodbridge 6
Boston 5
Charlotte 5
Council Bluffs 5
Guayaquil 5
Lugano 5
Milan 5
New Delhi 5
Philadelphia 5
Rio de Janeiro 5
Riyadh 5
San Jose 5
Secaucus 5
Terni 5
Vancouver 5
Zhengzhou 5
Abidjan 4
Belo Horizonte 4
Betim 4
Brasília 4
Buenos Aires 4
Totale 4.546
Salva come PNG Salva come JPEG
Nome #
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 119
Wnt/beta-Catenin Signaling Induces Integrin alpha 4 beta 1 in T Cells and Promotes a Progressive Neuroinflammatory Disease in Mice 114
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 111
Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment 110
LACK OF GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) RESULTS IN B CELL LYMPHOPROLIFERATIVE DISORDER IN MICE 109
GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling 101
GILZ REGULATES PRODUCTION OF PTREG AND TTREG CELLS AND IS NECESSARY FOR GLUCOCORTICOID-MEDIATED INDUCTION OF TREG CELLS 100
Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice 99
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 98
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 97
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 96
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 94
Glucocorticoid indeced lLeucine Zipper protein (GILZ) regulates Hematopoietic stem cell engrafment and myeloid differentiation in a mouse model of CEBPA mutant acute myeloid leukemia 92
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 92
Glucocorticoid and B cell development: role of Glucocorticoid-induced leucine zipper 91
Glucocorticoid-induced leucine Zipper (GILZ) controls T lymphocytes differentation 90
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 90
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 89
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 87
Glucocorticoid-induced leucine Zipper (GILZ) anf the new isoform L-GILZ mediates the anti-inflammatory effects of glucocorticoids 86
GILZ regulates the development of Treg cells via regulation of crosstalk between Glucocorticoids and TGF-beta 86
Role of GILZ in mediating the anti-inflammatory actions of glucocorticoids 85
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 85
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 85
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 84
Long- Glucocrticoid induced Leucine Zipper interacts with Ras pathway and is essential for spermatogenesis 81
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 80
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 80
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 79
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 79
Long-glucocorticoid-induced leucine zipper (L-GILZ) expression as a new diagnostic biomarker for male infertility associated with exposure to electromagnetic fields and radiofrequency radiation. 78
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 78
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 77
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 77
The effect of Ara-C treatment on hematopoietic stem cell expasion and leukemogenesis in a mouse model of CEBPA mutant acute myeloid leukemia 76
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 76
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 76
Bile Acid Signaling in Inflammatory Bowel Diseases 76
Bile Acids Activated Receptors Regulate innate immunity 75
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 75
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 75
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 75
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 75
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 75
Bile Acids Activated Receptors in Inflammatory Bowel Disease 74
Recombinant long-Glucocorticoid-induced leucine zipper (L-GILZ) protein restores the control of proliferation in gilz KO spermatogonia 73
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 73
Bile acids and their receptors in metabolic disorders 73
Glucocorticoid-induced leucine zipper (GILZ) is involved in Th2-mediated oxazolone-induced colitis 71
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 71
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 70
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 68
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 68
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH) 68
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 67
Glucocorticoid-induced leucine zipper (GILZ) is a regulator of intestina immune homeostatsis and anti-inflammatory effects of glucocorticoids 67
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 66
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 66
REGULATION OF HEMATOPOIETIC STEM CELL (HSC) DEVELOPMENT: ROLE OF GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) 66
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 66
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 65
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 64
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 64
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 63
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 62
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 61
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 61
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease 60
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 60
The identification of farnesoid X receptor modulators as treatment options for non-alcoholic fatty liver disease 60
Immunomodulatory functions of FXR 60
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 59
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 59
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 57
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 57
Bile acids and bile acid activated receptors in the treatment of Covid-19 56
Glucocorticoid-Induced Leucine Zipper (GILZ) controls inflammation and tissue damage after spinal cord injury. 56
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity 56
Sa1931 – Physico-Chemistry, Proteomics and In Vivo Comparative Tests to Reveal Variability in Multistrain Probiotic Formulations 55
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 54
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 54
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 53
Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis 52
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 50
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 50
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 49
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 49
Navigation in bile acid chemical space: Discovery of novel FXR and GPBAR1 ligands 46
Future trends in the treatment of non-alcoholic steatohepatitis 45
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 44
Immunology of bile acids regulated receptors 43
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics 42
Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases 41
BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile 40
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 39
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments 39
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 38
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis 36
Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists 36
Bile acids and their receptors in hepatic immunity 36
Totale 7.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 22 23 18 17 26 17 106
2021/2022673 13 143 7 16 14 6 38 175 15 69 88 89
2022/20231.378 90 242 14 124 132 123 2 82 495 3 55 16
2023/2024563 31 48 20 17 22 3 141 31 31 20 122 77
2024/20251.628 21 139 87 77 151 126 116 131 315 78 268 119
2025/20262.015 238 248 189 556 578 206 0 0 0 0 0 0
Totale 7.144